Synthesis of 18F-labeled fluconazole and positron emission tomography studies in rabbits.
暂无分享,去创建一个
N. Alpert | A. Fischman | R. Dahl | J. Correia | E. Livni | D. Elmaleh | S. Ray | D. Webb | I. Sinclair | S. Weiß
[1] R. Larsen. Azoles and AIDS. , 1990, The Journal of infectious diseases.
[2] J. K. Faulkner,et al. Pharmacokinetics and tissue penetration of fluconazole in humans. , 1990, Reviews of infectious diseases.
[3] M. Tarbit,et al. Discovery of fluconazole, a novel antifungal agent. , 1990, Reviews of infectious diseases.
[4] S. Berk,et al. Review of recent pneumococcal infections with attention to vaccine and nonvaccine serotypes. , 1990, Reviews of infectious diseases.
[5] K. Richardson. The discovery and profile of fluconazole. , 1990, Journal of chemotherapy.
[6] S. Kelly,et al. Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals. , 1989, Biochemical and biophysical research communications.
[7] P. Vanparys,et al. Toxicological Profile and Safety Evaluation of Antifungal Azole Derivatives , 1989, Mycoses.
[8] R. Rubin,et al. Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. , 1989, Transplantation.
[9] P. Ebden,et al. Sputum levels of fluconazole in humans , 1989, Antimicrobial Agents and Chemotherapy.
[10] T. Walsh,et al. Pharmacokinetics and tissue penetration of fluconazole in rabbits , 1989, Antimicrobial Agents and Chemotherapy.
[11] D. Weidler,et al. Steady State Parenteral Kinetics of Fluconazole in Man , 1988, Annals of the New York Academy of Sciences.
[12] M. Tarbit,et al. Design and Evaluation of a Systemically Active Agent, Fluconazole , 1988, Annals of the New York Academy of Sciences.
[13] D. Debruyne,et al. Determination of fluconazole in biological fluids by capillary column gas chromatography with a nitrogen detector. , 1988, Journal of pharmaceutical sciences.
[14] A. Catanzaro,et al. Fluconazole Penetration into Cerebrospinal Fluid in Humans , 1988, Journal of clinical pharmacology.
[15] M. Saag,et al. Azole antifungal agents: emphasis on new triazoles , 1988, Antimicrobial Agents and Chemotherapy.
[16] F. Balis,et al. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. , 1988, The Journal of infectious diseases.
[17] M J Humphrey,et al. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans , 1985, Antimicrobial Agents and Chemotherapy.
[18] H. Bossche. Biochemical Targets for Antifungal Azole Derivatives: Hypothesis on the Mode of Action , 1985 .
[19] H. van den Bossche,et al. Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. , 1983, Biochemical Society transactions.
[20] H. van den Bossche,et al. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis , 1980, Antimicrobial Agents and Chemotherapy.
[21] E. Corey,et al. Dimethyloxosulfonium Methylide ((CH3)2SOCH2) and Dimethylsulfonium Methylide ((CH3)2SCH2). Formation and Application to Organic Synthesis , 1965 .
[22] D. B. Duncan. MULTIPLE RANGE AND MULTIPLE F TESTS , 1955 .